US FDA seeks fast review of COVID-19 products: Commissioner Stephen Hahn
Since the onset of the COVID-19 pandemic earlier this year, the FDA has issued a series of temporary emergency approvals ranging…
Author
Anti-inflammatory and cancer drugs tested in UK as possible COVID-19 therapy
Izana Bioscience's Namilumab, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory…
AstraZeneca blood cancer drug shows signs of helping COVID-19 patients
Results from the preliminary research involving 19 patients, which was backed by the United States National Institutes of Health,…
Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug
The experimental drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through…
COVID-19 drug research may drag on into July: Fujifilm
Researchers have only been able to get around 70 per cent of the patients needed for the trials
Australia’s CSL says to help fund, make vaccine candidate if it proves successful
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the…
Novavax gets US defense funding for its COVID-19 vaccine
The US-based company said the deal includes the delivery of 10 million doses of its COVID-19 vaccine - NVX‑CoV2373 - to the DoD…
Lonza sets new goal to make Moderna COVID-19 vaccine ingredients
Moderna, which enlisted Lonza in May in a 10-year manufacturing contract, is racing with 100-plus other vaccine projects, having…
Reasonable to expect some coronavirus vaccine by year-end: US Army vaccine researcher
US Defense Secretary Mark Esper vowed on May 15 that the US military and other parts of the government would, in collaboration…
Gilead’s remdesivir shows modest improvement in moderate COVID-19 patients
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal…